CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.

Abstract excerpt

Gain-of-function mutations in KIT, a member of the receptor type tyrosine kinases, are observed in certain neoplasms, including mast cell tumors (MCTs) and acute myelogenous leukemias (AMLs). A MCT line HMC1.2 harboring the KIT mutation was reported to express CD72, which could suppress the cell proliferation. Here, we examined the ability of CD72 to modify the growth of AMLs harboring gain-of-function KIT...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antigens, Differentiation, B-Lymphocyte
• Share to Caspase 3